Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Scientific Session

Myositis

Session: Management of Challenging Cases in Myositis

Decoding Anti-Synthetase Syndrome

Sunday, October 26, 2025
9:00 AM – 9:30 AM Central Time

    Speaker(s)

  • Rohit Aggarwal, MD,MS (he/him/his)

    Professor
    University of Pittsburgh
    Pittsburgh, Pennsylvania, United States

    Disclosure(s): Alexion: Consultant (Ongoing); ANI Pharmaceuticals: Consultant (Ongoing); Argenx: Consultant (Ongoing); Artasome: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Cabaletta Bio: Consultant (Ongoing); Capella Bioscience: Consultant (Ongoing); Capstanx: Consultant (Ongoing); Corbus: Consultant (Ongoing); CSL Behring: Consultant (Ongoing); EMD Serono: Consultant (Ongoing), Grant/Research Support (Ongoing); Galapagos: Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing); I-Cell: Consultant (Ongoing); Immunovant: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Kezar: Consultant (Ongoing); Kyverna: Consultant (Ongoing); Lilly: Consultant (Ongoing); Manta Medicines: Consultant (Ongoing); Nkarta: Consultant (Ongoing); Novartis: Consultant (Ongoing); Nuvig Therapeutics: Consultant (Ongoing); Octapharma: Consultant (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); PRoivant: Consultant (Ongoing), Grant/Research Support (Ongoing); Teva: Consultant (Ongoing); Tourmaline Bio: Consultant (Ongoing); Verismo Therapeutics: Consultant (Ongoing)